78 related articles for article (PubMed ID: 21093979)
1. Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
Muñoz-Gámez JA; Quiles-Pérez R; Ruiz-Extremera A; Martín-Álvarez AB; Sanjuan-Nuñez L; Carazo A; León J; Oliver FJ; Salmerón J
Cancer Lett; 2011 Feb; 301(1):47-56. PubMed ID: 21093979
[TBL] [Abstract][Full Text] [Related]
2. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
García S; Bodaño A; Pablos JL; Gómez-Reino JJ; Conde C
Ann Rheum Dis; 2008 May; 67(5):631-7. PubMed ID: 17890271
[TBL] [Abstract][Full Text] [Related]
4. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
Luo Q; Li Y; Deng J; Zhang Z
Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136
[TBL] [Abstract][Full Text] [Related]
6. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH
Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
Sharma SS; Kumar A; Kaundal RK
Life Sci; 2008 Mar; 82(11-12):570-6. PubMed ID: 18262571
[TBL] [Abstract][Full Text] [Related]
8. Benzamide and 4-amino 1,8 naphthalimide treatment inhibit telomerase activity by down-regulating the expression of telomerase associated protein and inhibiting the poly(ADP-ribosyl)ation of telomerase reverse transcriptase in cultured cells.
Ghosh U; Bhattacharyya NP
FEBS J; 2005 Aug; 272(16):4237-48. PubMed ID: 16098204
[TBL] [Abstract][Full Text] [Related]
9. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
Luo Q; Li Y; Lai Y; Zhang Z
J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
[TBL] [Abstract][Full Text] [Related]
11. The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells.
Zheng YD; Xu XQ; Peng F; Yu JZ; Wu H
Oncol Rep; 2011 May; 25(5):1399-405. PubMed ID: 21399878
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
Holl V; Coelho D; Weltin D; Hyun JW; Dufour P; Bischoff P
Anticancer Res; 2000; 20(5A):3233-41. PubMed ID: 11062748
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
Radons J; Heller B; Bürkle A; Hartmann B; Rodriguez ML; Kröncke KD; Burkart V; Kolb H
Biochem Biophys Res Commun; 1994 Mar; 199(3):1270-7. PubMed ID: 8147870
[TBL] [Abstract][Full Text] [Related]
16. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
17. PARP-1 is involved in autophagy induced by DNA damage.
Muñoz-Gámez JA; Rodríguez-Vargas JM; Quiles-Pérez R; Aguilar-Quesada R; Martín-Oliva D; de Murcia G; Menissier de Murcia J; Almendros A; Ruiz de Almodóvar M; Oliver FJ
Autophagy; 2009 Jan; 5(1):61-74. PubMed ID: 19001878
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Brock WA; Milas L; Bergh S; Lo R; Szabó C; Mason KA
Cancer Lett; 2004 Mar; 205(2):155-60. PubMed ID: 15036647
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by the inhibitors of poly(ADP-ribose)polymerase in HeLa cells.
Ghosh U; Bhattacharyya NP
Mol Cell Biochem; 2009 Jan; 320(1-2):15-23. PubMed ID: 18695944
[TBL] [Abstract][Full Text] [Related]
20. [Effect of PARP-1 inhibitor 4-amino-1 ,8-naphthalimide on the on the sensitivity of adriamycin].
Jiang X; Liu S; Deng W; Zhao W; Wu M; Zhang Z
Wei Sheng Yan Jiu; 2012 Mar; 41(2):173-9. PubMed ID: 22611920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
